Earnings call transcript: DXP Enterprises Q1 2026 misses forecasts, stock drops

DXP Enterprises reported Q1 2026 EPS of $1.26, missing the $1.33 consensus, while revenue of $521.7 million came in slightly below the $522.1 million forecast. Despite 9.5% year-over-year sales growth and 79 bps gross margin expansion to 32.3%, higher SG&A and one-time costs pressured results, and the stock fell 17.35% pre-market. Management said demand remains solid in energy and water markets, with Innovative Pumping Solutions sales up 37.7% and acquisition activity continuing.

Analysis

The market is treating this like a clean earnings miss, but the more important signal is that the business is becoming increasingly mix-sensitive. The segment with the highest growth and best backlog visibility is also the one most exposed to long-cycle project timing, so a single soft month can create an exaggerated near-term drawdown even if the underlying demand tape is intact. That dynamic tends to favor a fast mean reversion in the stock once investors see the next monthly cadence improve, but it also means the name will trade like a quality cyclically levered compounder rather than a defensive industrial.

The bigger second-order issue is leverage to acquisition integration and working capital absorption. As the company layers in more deals, SG&A normalization may lag revenue growth for several quarters because legal, healthcare, audit, and onboarding costs scale before revenue synergies do. That makes margin expansion less linear than bulls expect; the upside case is not just end-market demand but proof that incremental acquisitions are accretive without dragging cash conversion or causing receivable days to keep creeping up.

For competitors, this is mildly negative for smaller industrial distributors and pump/service peers chasing the same water, energy, and infrastructure wallet share. If this management team can keep backlog converting while competitors remain priced on cleaner margins, DXP can keep using M&A as a growth engine, which pressures regional rivals to either pay up for assets or concede share. The contrarian takeaway is that the selloff may be overdone if the market is anchoring on the EPS miss rather than on the company’s ability to monetize delivery speed, backlog, and mix shift over the next 2-3 quarters.

The key risk is that the stock was already priced for perfection, so any evidence that January was not a one-off but a demand air pocket would force multiple compression rather than a simple rebound. If April and May hold the improved run-rate, the path of least resistance is a recovery in the next 30-60 days; if not, this can de-rate quickly because the equity is not cheap enough to absorb another quarter of SG&A noise without visible upside revisions.

Key Decisions for Investors

• Short-term: buy the post-earnings selloff in DXPE only on confirmation of sustained monthly acceleration; use a 2-4 week horizon and size for a 10-15% rebound if April/May revenue cadence holds.
• For more convexity, initiate a small DXPE June/July put spread against the first bounce; thesis is that valuation and acquisition-related cost noise can keep the stock under pressure if the market starts questioning margin normalization.
• Pair trade: long DXPE / short a lower-quality industrial distributor or MRO peer with weaker backlog visibility over the next 1-2 quarters; if DXP’s mix shift and backlog conversion stay intact, it should outperform peers even if the sector stays range-bound.
• If you already own DXPE, hedge into strength with call overwrites around the next earnings cycle; implied volatility should remain elevated, and upside may be more gradual than the current drawdown suggests.
• Watch for a tactical add only if management demonstrates receivable days and SG&A leverage improving over the next quarter; absent that, the right risk/reward is to wait for evidence rather than average down immediately.